Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2015

View Archived Issues

Caladrius signs agreement to explore next-generation strategies for core cancer technology

City of Hope studying CAR T-cell therapy for brain cancers

Teva and Microchips Biotech partner on implantable drug delivery device

New round of funding to support Batu Biologics' development of ValloVax

Dementia Consortium funds drug discovery project in brain inflammation

Celon presents data on new PI3Kdelta inhibitor

First-in-human results reported for MLN-1117 in patients with solid tumors

Final data confirm benefit of imeglimin in phase IIb diabetes trial

Results for CR-6086 in preclinical models of rheumatoid arthritis

Kite Pharma and bluebird bio to advance second-generation TCR cell therapy products

Forum Pharmaceuticals' encenicline receives FDA fast track designation

Fujifilm updates development of radiopharmaceuticals for neuroendocrine tumors

3SBio acquires global rights to anti-TNF MAb

New AAV-based gene therapy presented for the treatment of brain arteriovenous malformation

Ampio Pharmaceuticals reports additional data for Optina in diabetic macular edema

IOmet Pharma patents IDO/TDO inhibitors

Bayer Schering Pharma describes GnRH receptor antagonists

University of Illinois and the Hong Kong Baptist University report anticancer maytansinoids

Allergan develops CCR2 antagonists

Team in Israel presents RNA polymerase I inhibitors

OphthaliX to acquire Improved Vision Systems

Kythera launches Kybella in U.S.

Pfizer to acquire Nimenrix and Mencevax from GSK

FDA approves Kengreal as adjunctive to PCI for reducing thrombotic events

Vaxil's ImMucin designated FDA orphan drug for multiple myeloma

Isis reports findings from extension study of ISIS-SMNRx in spinal muscular atrophy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....